Logo for Pyxis Oncology Inc

Pyxis Oncology Inc Investor Relations Material

Latest events

Logo for Pyxis Oncology Inc

M&A Announcement

Pyxis Oncology Inc
Logo for Pyxis Oncology Inc

Q4 2023

21 Mar, 2024
Logo for Pyxis Oncology Inc

Corporate Presentation

19 Dec, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Pyxis Oncology Inc

Access all reports
Pyxis Oncology Inc. is a clinical-stage biopharmaceutical company focused on developing therapies to treat cancer. It is focused on helping patients with cancer through a differentiated portfolio of biologics, specifically targeting tumor cells and overcoming immune suppression. Pyxis Oncology's strategy encompasses the use of antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies, aiming to improve outcomes for patients with difficult-to-treat cancers. The company is headquartered in Boston, MA, and its shares are listed on the Nasdaq.